Weekly Spotlight - 21.11.24

Community

We want to hear your story!

Fill in the form to share your experiences and any challenges you’ve faced living with your condition, for a chance to be featured in one of our weekly newsletters!

Latest News

Oral Infigratinib Shows Promise as Safe Treatment for Children with Common Dwarfism Condition

The article discusses a new oral medication called infigratinib, which has been found to be safe for children with achondroplasia, a common form of dwarfism. The drug aims to improve bone growth and reduce the risk of related health issues in these children. Initial trials show promising results with minimal side effects.

Community Rallies for Athlete with Dwarfism to Compete in Local Track Events Despite Rules Barriers

The article discusses the community's support for Hugo, a young boy with achondroplasia, who was initially disqualified from participating in a school sports event due to safety concerns. The community rallied around him, advocating for his right to participate and highlighting the importance of inclusion and equality in sports.

Police Dispatcher Undergoes Life-Changing Spinal Surgery After Years of Pain

A police dispatcher with achondroplasia underwent serious spinal surgery to alleviate severe back pain and improve her quality of life. The procedure involved fusing multiple vertebrae to stabilize her spine and reduce the risk of further complications. The surgery was successful, and she is recovering well.

BioMarin Presents Real-World Evidence Supporting Safety and Efficacy of Treatment in Patients.

BioMarin presents real-world evidence supporting the safety and efficacy of vosoritide, a treatment for achondroplasia. The data shows positive outcomes in terms of growth and safety profiles, providing further confidence in the treatment's benefits for individuals with achondroplasia.